The European Medicines Agency recently launched a public consultation on draft questions and answers on production of water for injections by non-distillation methods – reverse osmosis and biofilms and control strategies. EIPG has reviewed the document and, following feedback from its members, has submitted its comments to the EMA.
-
-
News from EIPG
- The EU Parliament voted its position on the Unitary SPC
- Reform of pharma legislation: the debate on regulatory data protection
- Environmental sustainability: the EIPG perspective
- How AI is Changing the Pharma Industry and the Industrial Pharmacist’s Role
- Generative AI in drug development
- PGEU annual medicine shortages report
- EMA’s pilot scheme for academic and non-profit development of ATMPs